SITAGLIPTIN + METFORMIN (50MG/500MG)

Management Of Type 2 Diabetes Mellitus

Combined Dosage As Prescribed

This Combination Medication Contains Sitagliptin And Metformin, Utilized For Managing Type 2 Diabetes. Metformin Reduces Gluconeogenesis In The Liver And Increases Insulin Sensitivity, While Sitagliptin Increases Incretins To Regulate Insulin Release. This Synergistic Effect Provides Comprehensive Glycemic Control, Making It An Effective Treatment Option For Patients Who Require Multiple Mechanisms To Control Blood Glucose Levels.

Hypersensitivity Pregnancy Severe Renal Impairment

Monitor Liver Function Risk Of Lactic Acidosis In Renal Impairment